KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Treasury Shares: 2009-2025

Historic Treasury Shares for Exact Sciences (EXAS) over the last 15 years, with Sep 2025 value amounting to $7.7 million.

  • Exact Sciences' Treasury Shares rose 2.25% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 million, marking a year-over-year increase of 2.25%. This contributed to the annual value of $7.2 million for FY2024, which is 15.50% up from last year.
  • According to the latest figures from Q4 2009, Exact Sciences' Treasury Shares is $97,000.
  • In the past 5 years, Exact Sciences' Treasury Shares registered a high of $97,000 during Q4 2009, and its lowest value of $97,000 during Q4 2009.
  • For the 3-year period, Exact Sciences' Treasury Shares averaged around $7.4 million, with its median value being $7.5 million (2024).
  • Its Treasury Shares has fluctuated over the past 5 years, first fell by 7.49% in 2021, then spiked by 34.94% in 2022.
  • Quarterly analysis of 5 years shows Exact Sciences' Treasury Shares stood at $4.3 million in 2021, then increased by 21.61% to $5.3 million in 2022, then increased by 19.37% to $6.3 million in 2023, then grew by 15.50% to $7.2 million in 2024, then increased by 2.25% to $7.7 million in 2025.
  • Its Treasury Shares stands at $7.7 million for Q3 2025, versus $8.1 million for Q2 2025 and $8.4 million for Q1 2025.